Literature DB >> 20945094

Predictive algorithms: uses and limitations.

Janice H Jou, Deborah A Fisher.   

Abstract

Mesh:

Year:  2010        PMID: 20945094     DOI: 10.1007/s10620-010-1436-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  5 in total

1.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

2.  Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.

Authors:  Brenda K Edwards; Elizabeth Ward; Betsy A Kohler; Christie Eheman; Ann G Zauber; Robert N Anderson; Ahmedin Jemal; Maria J Schymura; Iris Lansdorp-Vogelaar; Laura C Seeff; Marjolein van Ballegooijen; S Luuk Goede; Lynn A G Ries
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

3.  Surveillance for hepatocellular carcinoma: development and validation of an algorithm to classify tests in administrative and laboratory data.

Authors:  Peter Richardson; Louise Henderson; Jessica A Davila; Jennifer R Kramer; Conar P Fitton; G John Chen; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2010-09-16       Impact factor: 3.199

4.  Randomized controlled trial of screening for hepatocellular carcinoma.

Authors:  Bo-Heng Zhang; Bing-Hui Yang; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

5.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Authors:  V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 176.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.